ライフサイエンスコーパス: serine protease inhibitor

1 a-1 (apoptosis related) and reduced Clade-B (serine protease inhibitor).

2 ion movement, all of which were blocked by a serine protease inhibitor.

3 rigidity which may aid in its function as a serine protease inhibitor.

4 bited stoichiometrically by an electrophilic serine protease inhibitor.

5 ioactive peptide from the alpha1-antitrypsin serine protease inhibitor.

6 ypsin (AAT) is the most abundant circulating serine protease inhibitor.

7 Trypsin was strongly inhibited by serine protease inhibitor.

8 nd closely related Kunitz-type transmembrane serine protease inhibitors.

9 ignificant similarity to the Kazal family of serine protease inhibitors.

10 D34+ cells, but this effect was abrogated by serine protease inhibitors.

11 and EDTA but not by cysteine, aspartate, or serine protease inhibitors.

12 lytic effect of lactoferrin was prevented by serine protease inhibitors.

13 unit can form the basis for a novel class of serine protease inhibitors.

14 ibited by a prostasin antibody, heparin, and serine protease inhibitors.

15 ng new avenues for a systematic discovery of serine protease inhibitors.

16 y processing is inhibited by brefeldin A and serine protease inhibitors.

17 cular weight proteins classically defined as serine protease inhibitors.

18 e a large and functionally diverse family of serine protease inhibitors.

19 design templates for engineering reversible serine protease inhibitors.

20 phil response was sensitive to inhibition by serine protease inhibitors.

21 the myxobacterial crocapeptins proved to be serine protease inhibitors.

22 ains and its high homology with other Kunitz serine protease inhibitors.

23 of Ca(+2) ions and exclusively inhibited by serine protease inhibitors.

24 MSO)/Ringer's solution, 300 KIU aprotinin (a serine protease inhibitor), 0.05% or 0.10% IL-1 receptor

25 Deletion of the gene that encodes serine protease inhibitor 1 (SPI-1) of rabbitpox virus a

26 T. gondii serine protease inhibitor 1 (TgPI1) is the most abundant

27 d with pathologic enzyme activation (such as serine protease inhibitor 1) have been found in familial

28 storation of the deleted C12L gene, encoding serine protease inhibitor 1, enhances replication of MVA

29 ajority of patients harbor a mutation in the serine protease inhibitor 1A (SERPINA1) gene leading to

30 nt components, lipocalin-2, metallothionein, serine protease inhibitor-2, transferrin, tissue inhibit

31 The serine protease inhibitor 2A (Spi2a) was highly up-regul

32 The function of serine protease inhibitor 2A (Spi2A) was studied in mous

33 ed, at least in part, by the upregulation of Serine protease inhibitor 2A (Spi2A), a potent inhibitor

34 Here we report that the gene encoding serine protease inhibitor 2A (Spi2A), an inhibitor of ly

35 sed expression of serum amyloid A (Saa3) and serine protease inhibitor 3n (Serpina3n).

36 sion of a novel member of the serpin family, Serine protease inhibitor 4 (Spn4), that we propose is i

37 However, if mineralization was blocked with serine protease inhibitor 4-(2-aminoethyl)benzenesulfony

38 st different protease classes were screened, serine protease inhibitor 4-(2-aminoethyl)benzenesulfony

39 in the presence or absence of cell-permeant serine protease inhibitors 4-(2-aminoethyl)-benzenesulfo

40 with either a protease mixture, or specific serine protease inhibitors 4-(2-Aminoethyl)benzenesulfon

41 studies were designed to examine the role of serine protease inhibitor 6 (SPI-6) in limiting granzyme

42 Serine protease inhibitor 6 (SPI-6), also called Serpinb

43 We show in this study that although serine protease inhibitor 6 (Spi6) is required to protec

44 ression of GrB and its endogenous inhibitor, serine protease inhibitor 6 (Spi6) upon activation.

45 By using mice deficient in Serine Protease Inhibitor 6 (Spi6), we show that by inhi

46 Using mice deficient in serine protease inhibitor 6 (Spi6), we show that Spi6 pr

47 honuclear neutrophils from mice deficient in serine protease inhibitor 6, a weak intracellular NE inh

48 r, mice overexpressing the inhibitor of GZB, serine protease inhibitor 6, are also resistant to toler

49 demonstrated that constitutive expression of serine protease inhibitor 9 (PI-9) on hPB-MSCs and bone

50 ected human alveolar macrophages (AMs) found serine protease inhibitor 9 (PI-9) to be the most promin

51 Serine protease inhibitors abrogated both CPE and collag

52 issue factor pathway inhibitor-2 (TFPI-2), a serine protease inhibitor abundant in the extra cellular

53 The overexpressed human serine protease inhibitor accumulated in lung cells and

54 Incubation of hepatocytes with the serine protease inhibitor AEBSF reduced the death respon

55 The use of these serine protease inhibitors allows observations as to the

56 Genetic mutations predispose the serine protease inhibitor alpha(1)-antitrypsin to misfol

57 ase-3 (PR3), we determined the effect of the serine protease inhibitor alpha-1 antitrypsin (AAT) on I

58 everity can be dampened by administration of serine protease inhibitor alpha-1 antitrysin (AAT).(2)

59 One such protein is the serine protease inhibitor alpha-1-antichymotrypsin (ACT)

60 -c) and IgE-tp interact with polymers of the serine protease inhibitor alpha-1-antitrypsin (A1AT).

61 o have anti-inflammatory properties, and the serine protease inhibitors alpha-1-antitrypsin and alpha

62 caused by the Z mutation (Glu342Lys) in the serine protease inhibitor alpha1-antitrypsin (alpha1AT),

63 Treatment with the serine protease inhibitor alpha1-antitrypsin decreased s

64 M-DEX including, in addition to TIGR/MYOC, a serine protease inhibitor (alpha1-antichymotrypsin), a n

65 Elafin is an endogenous serine protease inhibitor and is transcriptionally down-

66 f the MBP cleavage site within L1 as well as serine protease inhibitors and an L1 peptide containing

67 Serine protease inhibitors and an S456A or an E431A poin

68 essing resistance to inhibition by canonical serine protease inhibitors and in cleaving these inhibit

69 y human and mouse neutrophils was blocked by serine protease inhibitors and was impaired in infected

70 S intercerebralis major Peptide C (PMP-C), a serine protease inhibitor, and that the EGF-CFC domains

71 binding, circulating immunoglobulin complex, serine protease inhibitors, and microtubule bundle forma

72 Serine proteases, serine protease inhibitors, and protease-activated recep

73 ferential regulation of serine proteases and serine protease inhibitors, and the identification of tr

74 2 or ALLN but was partially sensitive to the serine protease inhibitor APMSF.

75 Consistent with these results, the serine protease inhibitor aprotinin reproduced the effec

76 (aminocaproic acid and tranexamic acid), the serine protease inhibitor aprotinin, or no antibleeding

77 kinase plasminogen activator inhibitor-1 and serine protease inhibitor aprotinin.

78 ll carcinoma antigen-2 (SCCA-2/serpinb3a), a serine protease-inhibitor, are overexpressed in the airw

79 carbamoyl triazole TCMDC-134379 (1), a known serine protease inhibitor, as an excellent starting poin

80 i2A) was studied in mouse TH2 cells, and the serine protease inhibitor B3 (SERPINB3) and SERPINB4 gen

81 ng PDAC progression, AGRN (agrin), SERPINB5 (serine protease inhibitor B5), and CSTB (cystatin B).

82 A focused library of serine protease inhibitors based on diaryl phosphonate w

83 Protease nexin-1 (PN-1) is a serine protease inhibitor belonging to the serpin superf

84 SCO0762, a serine-protease inhibitor belonging to the Streptomyces

85 The reversible serine protease inhibitor, benzamidine, inhibited VesB a

86 ultiple human and murine cell lines and that serine protease inhibitors block Xps-mediated rounding a

87 A serine protease inhibitor blocked peptide and oligosacch

88 Both cell-permeant serine protease inhibitors blocked amylase secretion in

89 ine protease inhibitors, but not aspartic or serine protease inhibitors, blocked antibody-drug conjug

90 prior therapy (from the Retreatment with HCV Serine Protease Inhibitor Boceprevir and PegIntron/Rebet

91 naive patients) and the Retreatment With HCV Serine Protease Inhibitor Boceprevir and Pegintron/Rebet

92 A serine protease inhibitor but not inhibitors of cysteine

93 modulators of tumorigenesis/metastasis from serine protease inhibitors but also strengthens the func

94 of EKsolCorin was inhibited by trypsin-like serine protease inhibitors but not inhibitors of chymotr

95 This generation was sensitive to serine protease inhibitors but not to other classes of i

96 s treated with soy bean trypsin inhibitor, a serine protease inhibitor, but this inhibition is overco

97 ate by the C. parvum lysate was inhibited by serine protease inhibitors, by the specific furin inhibi

98 in inhibition, which is in contrast to other serine protease inhibitors (camostat mesylate and aproti

99 Serine protease inhibitors can block the gelatinase acti

100 ., plasminogen activator inhibitor-1 (PAI-1; serine protease inhibitor, clade E, member 1), connectiv

101 those of the previously characterized fungal serine protease inhibitors, cnispin from Clitocybe nebul

102 animals they are known to act as kinase and serine protease inhibitors controlling cell growth and d

103 In contrast, the serine protease inhibitor does not affect TRAIL-induced

104 s not inhibited significantly by Pefabloc (a serine protease inhibitor), EDTA (a metalloprotease inhi

105 alphavbeta(3) antibodies, RGD-peptide, and a serine protease inhibitor effectively blocked plasmin-in

106 native state dynamics of the small globular serine protease inhibitor eglin c has been studied in a

107 nanosecond time scale dynamics of the small serine protease inhibitor eglin c have been studied by N

108 ine mutations were introduced into the small serine protease inhibitor eglin c, and the (15)N and (2)

109 Because CI2 is a homologue of the serine protease inhibitor eglin c, which has already bee

110 The serine protease inhibitor, elafin, is a critical compone

111 Maspin, a noninhibitory serine protease inhibitor, exerts multifaceted tumor-sup

112 atic secretory trypsin inhibitor (PSTI) is a serine protease inhibitor, expressed in gut mucosa, whos

113 ng pathway and alpha1-antitrypsin protein (a serine protease inhibitor) expression and downregulation

114 StcE does not digest other serine protease inhibitors, extracellular matrix protein

115 umin and OVAY, OVAX belongs to the ovalbumin serine protease inhibitor family (ov-serpin).

116 nd protein expression of maspin, a member of serine protease inhibitor family and an epithelial cell

117 It is of interest that a member of the serine protease inhibitor family is concomitantly induce

118 , functional APC levels are regulated by the serine protease inhibitor family of proteins including a

119 SerpinB2, a member of the serine protease inhibitor family, is expressed by macrop

120 esterase inhibitor (C1-INH), a member of the serine protease inhibitor family.

121 Bikunin is a serine protease inhibitor found in human amniotic fluid,

122 creases once the expression of a Kunitz-type serine protease inhibitor from the American dog tick (De

123 eased the selectivity of ShPI-1, a versatile serine protease inhibitor from the sea anemone Stichodac

124 ibed a family of 14 Kazal-like extracellular serine protease inhibitors from P. infestans.

125 and structural similarities to extracellular serine protease inhibitors from the nematode Ascaris.

126 rotease activity by targeted deletion of the serine protease inhibitor gene Spink5 each increases inf

127 Matriptase and its cognate, Kunitz-type serine protease inhibitor, HAI-1, comprise a newly chara

128 SPINT2 encodes the transmembrane serine protease inhibitor HAI2 (placental bikunin), and

129 ine-alpha-methylpyrrolidine-5,5-trans-lactam serine protease inhibitors has been developed as antivir

130 reported discovery in 1994, maspin (mammary serine protease inhibitor) has been characterized as a c

131 ore, C1INH, in addition to its function as a serine protease inhibitor, has a novel anti-inflammatory

132 on in the absence of the cognate Kunitz-type serine protease inhibitors, hepatocyte growth factor act

133 (Although aprotinin is a serine protease inhibitor, here we use the term antifibr

134 rotein (IalphaIp) functions as an endogenous serine protease inhibitor in human plasma, and IalphaIp

135 nhibitor protein (IalphaIp) is an endogenous serine protease inhibitor in human plasma.

136 likely that induction of both IRF-1 and the serine protease inhibitor in response to infection by M.

137 nents of the Toll and JAK/STAT pathways, and serine protease inhibitors in both social and solitary b

138 alpha inhibitor proteins serve as endogenous serine protease inhibitors in human plasma.

139 guishing cospin from other beta-trefoil-fold serine protease inhibitors in which beta4-beta5 or beta5

140 Treatment with FUT-175 (10 mg/kg), a potent serine protease inhibitor, increased survival after I-R,

141 parison of the LTI sequence with other known serine protease inhibitors indicates that LTI is a membe

142 5B polymerase inhibitor, and GS-9256, an NS3 serine protease inhibitor, individually have activity ag

143 iruses upregulates a cellular protein called serine protease inhibitor Kazal (SPIK).

144 inogen (PRSS1), anionic trypsinogen (PRSS2), serine protease inhibitor Kazal 1 (SPINK1), cystic fibro

145 Degradation of the protective serine protease inhibitor Kazal type 1 (SPINK1) by mesot

146 Here we show that tumor-cell-expressed serine protease inhibitor Kazal type 1 (SPINK1) is a key

147 static associations between filaggrin (FLG), serine protease inhibitor Kazal-type 5 (SPINK5), and thy

148 tly, we identified SPINK5, which encodes the serine protease inhibitor Kazal-type 5 protein (LEKTI),

149 The loss-of-function mutations of serine protease inhibitor, Kazal type 1 (SPINK1) gene ar

150 In a preliminary study, we found serine protease inhibitor, Kazal type 1 (SPINK1) mutatio

151 static function of a five-domain Kunitz-type serine protease inhibitor (KPI) from the tick Dermacento

152 These genes included that encoding the serine protease inhibitor Kunitz type 1 (Spint1), which

153 Deficiency in the serine protease inhibitor LEKTI is the etiological origi

154 SPINK5, encoding the putative multi-domain serine protease inhibitor LEKTI, was recently identified

155 rated in SPINK5-deficient mice that lack the serine protease inhibitor LEKTI.

156 e inhibition of protease activity by using a serine protease inhibitor leupeptin or two structurally

157 derivatives in disease states with elevated serine protease inhibitor levels.

158 Vaspin (visceral adipose tissue-derived serine protease inhibitor) levels increase with hyperins

159 c alpha-amylase inhibitor CM2 (Tri a 29.02), serine protease inhibitor-like allergen (Tri a 39), and

160 The variant is located in the gene encoding serine protease inhibitor, low levels of which are assoc

161 f lamellar bodies; SPINK5, which encodes the serine protease inhibitor lymphoepithelial Kazal-type tr

162 We have targeted the Mammary Serine Protease Inhibitor (maspin) (SERPINB5) tumor supp

163 Mammary serine protease inhibitor (Maspin) represents an importa

164 g domains it also contains several "serpin" (serine protease inhibitor) motifs.

165 Maspin is a unique serine protease inhibitor of which the down-regulation i

166 Naturally-occurring serine protease inhibitors of the Bowman-Birk family exe

167 thora infestans, secrete a diverse family of serine protease inhibitors of the Kazal family.

168 Serine protease inhibitors of the Kunitz-bovine pancreat

169 The suicide inhibitory mechanism of serine protease inhibitors of the serpin superfamily dep

170 onic acids include biochemically significant serine protease inhibitors, one of which is the clinical

171 eatments of C57/BL6J-betaENaC-Tg mice with a serine protease inhibitor ONO-3403, a derivative of camo

172 Maspin is a mammary serine protease inhibitor or serpin with tumor suppressi

173 Penetration was prevented by addition of serine protease inhibitors or a chicken monoclonal antib

174 of CDCP1 with unique anti-CDCP1 antibodies, serine protease inhibitors or genetic modulation of the

175 Serine protease inhibitors, or serpins, are paradigms fo

176 This serine protease inhibitor participates in the regulation

177 The serine protease inhibitors phenylmethylsulfonyl fluoride

178 This degradation was inhibited by serine protease inhibitors phenylmethylsulfonyl fluoride

179 ivity of BRS1 can be strongly inhibited by a serine protease inhibitor, phenylmethylsulfonyl fluoride

180 translational processing is inhibited by the serine protease inhibitor, phenylmethylsulfonyl fluoride

181 sive activities of CDCP1 by upregulating the serine protease inhibitor plasminogen activator inhibito

182 urthermore, stable transfection of a related serine protease inhibitor, plasminogen activator inhibit

183 This was suppressed by serine protease inhibitors (PMSF, Pefabloc SC), but not

184 This activity could not be inhibited by a serine protease inhibitor, PMSF, but could be inhibited

185 In summation, novel and potent trypsin-like serine protease inhibitors possessing a unique mode of b

186 inogen activator and urokinase, as well as a serine protease inhibitor, PP5.

187 alpha1-Antitrypsin is a serine protease inhibitor produced in the liver that is

188 n alpha1-antitrypsin (hAAT), the major serum serine-protease inhibitor, prolongs islet graft survival

189 Here, we identify the serine protease inhibitor protease nexin 1 (PN1) as a ne

190 d Western blotting analyses, revealed that a serine protease inhibitor, protease nexin-1 (PN-1), was

191 ctor, interleukin 1 receptor antagonist, and serine protease inhibitor protein 1, and the phosphoryla

192 The serpin family of serine protease inhibitors provides a well-defined struc

193 A serine protease inhibitor reduced saliva-mediated enhanc

194 Although aprotinin, a serine protease inhibitor, reduces blood loss in patient

195 Serpins (serine protease inhibitors) regulate some innate immune

196 inogen activator inhibitor type 2 (PAI-2), a serine protease inhibitor, resulted in NLRP3- and ASC (a

197 alpha(1)-Antitrypsin is a serine protease inhibitor secreted by hepatocytes.

198 ficantly increased neurogenesis, whereas the serine protease inhibitor, secretory leukocyte protease

199 neutrophil apoptosis and efferocytosis in a serine-protease inhibitor-sensitive manner.

200 The human serine protease inhibitor (serpin) alpha-1 antitrypsin (

201 Many members of the serine protease inhibitor (serpin) family are activated

202 The serine protease inhibitor (serpin) family can readily fo

203 at secreted proteins Fibronectin 1 (FN1) and serine protease inhibitor (serpin) family E member 2 (SE

204 rcinoma antigen 1 (SCCA1) is a member of the serine protease inhibitor (serpin) family of proteins, w

205 We have identified a member of the serine protease inhibitor (serpin) family which is highl

206 elium-derived factor (PEDF), a member of the serine protease inhibitor (serpin) family, is a survival

207 Maspin, a member of the serine protease inhibitor (serpin) family, is a tumor su

208 inhibitor type-1 (PAI-1) is a member of the serine protease inhibitor (serpin) family.

209 The human serine protease inhibitor (serpin) gene cluster at 14q32

210 The human serine protease inhibitor (serpin) gene cluster at 14q32

211 The human serine protease inhibitor (serpin) gene cluster at 14q32

212 ine residues important for inhibition by the serine protease inhibitor (serpin) heparin cofactor II (

213 ogen activator inhibitor type-1 (PAI-1) is a serine protease inhibitor (serpin) implicated in numerou

214 ogen activator inhibitor type 1 (PAI-1) is a serine protease inhibitor (serpin) in which the reactive

215 igment epithelium-derived factor (PEDF) is a serine protease inhibitor (serpin) protein with well est

216 Maspin is a member of the serine protease inhibitor (serpin) superfamily and displ

217 Point mutations cause members of the serine protease inhibitor (serpin) superfamily to underg

218 Maspin is a non-inhibitory serine protease inhibitor (serpin) that influences many

219 asminogen activator inhibitor-1 (PAI-1) is a serine protease inhibitor (serpin) that regulates fibrin

220 Maspin is a novel serine protease inhibitor (serpin) with tumor suppressiv

221 Maspin, a serine protease inhibitor (serpin), can suppress tumor g

222 Maspin, a novel serine protease inhibitor (serpin), suppresses the growt

223 xamined the unique relationship of maspin, a serine protease inhibitor (serpin), that plays a critica

224 ene that encodes the C1 inhibitor (C1INH), a serine protease inhibitor (serpin).

225 Expression of two serine protease inhibitors [Serpina1a (alpha1-antitrypsi

226 , we observed a compensatory increase in the serine protease inhibitor Serpina3n in mouse models of M

227 Elevated levels of the serine protease inhibitors SERPINB3 and SERPINB4 are see

228 Genetic ablation of serine protease inhibitor SerpinB9 (Sb9) results in the

229 rand in a manner similar to that observed in serine protease inhibitors serpins.

230 Serine protease inhibitors (serpins) are a superfamily o

231 designed to determine if S-glutathionylated serine protease inhibitors (serpins) in blood could be u

232 The native form of serine protease inhibitors (serpins) is kinetically trap

233 nomodulating genes with sequence homology to serine protease inhibitors (serpins) that possess antiap

234 ctor 15 (GDF15), stanniocalcin 1 (STC1), and serine protease inhibitors (SERPINs), which significantl

235 mmatory properties with sequence homology to serine protease inhibitors (serpins).

236 arks of such cascades is their regulation by serine protease inhibitors (serpins).

237 rpin superfamily proteins, most of which are serine protease inhibitors, share an unusual mechanism r

238 vel bifunctional metallocarboxypeptidase and serine protease inhibitor (SmCI) isolated from the tenta

239 we show that soymilk and the soybean-derived serine protease inhibitors soybean trypsin inhibitor and

240 Previously, we showed that maspin, a serine protease inhibitor, specifically inhibits PC-asso

241 Serine protease inhibitor (Spi) 2A, an anti-apoptotic cy

242 ort that memory cells express high levels of serine protease inhibitor (Spi) 6, an inhibitor of the e

243 A novel filarial serine protease inhibitor (SPI) from the human parasitic

244 This study has focused on the novel role of serine protease inhibitor (SPI) in the escape of MSCs fr

245 hese data suggest that in the absence of the serine protease inhibitor spink5, there is an abnormal i

246 Serine protease inhibitors (SPIs) regulate protease-medi

247 not efficiently inhibited by broad spectrum serine protease inhibitors, suggesting that the enzyme c

248 nd that maspin-a noninhibitory member of the serine protease inhibitor superfamily-translocates from

249 face-associated, and secreted protein in the serine protease inhibitor superfamily.

250 echanism of disease caused by mutants of the serine protease inhibitor superfamily.

251 at serpin5 (Spn5), a largely uncharacterized serine protease inhibitor, suppresses the melanization p

252 Maspin, a novel serine protease inhibitor, suppresses tumor progression

253 Serine protease inhibitors, termed serpins, are key regu

254 l)-benzenesulfonyl fluoride hydrochloride, a serine protease inhibitor that blocks activating transcr

255 -2-phenylethyl chloromethyl ketone (TPCK), a serine protease inhibitor that blocks IkappaBalpha degra

256 Chymostatin, a serine protease inhibitor that does not prevent the acti

257 tor-1 (HAI-1) is a Kunitz-type transmembrane serine protease inhibitor that forms inhibitor complexes

258 athway inhibitor-2 (TFPI-2) is a Kunitz-type serine protease inhibitor that inhibits plasmin, trypsin

259 CHFI is considered a canonical serine protease inhibitor that interacts with FXIIa thro

260 1 is an epithelial Kunitz-type transmembrane serine protease inhibitor that is encoded by the SPINT1

261 The HE4 gene encodes for a putative serine protease inhibitor that is upregulated in human a

262 (HAI-1) is a membrane-associated Kunitz-type serine protease inhibitor that regulates cell surface an

263 vator inhibitor-1 (HAI-1) is a transmembrane serine protease inhibitor that regulates the conversion

264 e domains and likely functions as a secreted serine protease inhibitor that targets two distinct prot

265 intact IRF-1 correlated with induction of a serine protease inhibitor that was able to significantly

266 Serine protease inhibitors that block CIAP1 cleavage inh

267 be common to a large class of tight-binding serine protease inhibitors that mimic good substrates.

268 Serpins are a family of serine protease inhibitors that regulate proteases of pl

269 In addition, increased expression of a serine protease inhibitor, the hepatocyte growth factor

270 and structure similar to a larger family of serine protease inhibitors, the Bowman-Birk inhibitors.

271 ratory post hoc analyses using data from the Serine Protease Inhibitor Therapy 2 (SPRINT-2) study (tr

272 Previously untreated patients (from the Serine Protease Inhibitor Therapy 2 [SPRINT-2] trial) an

273 strate the clinical potential for this novel serine protease inhibitor to prevent GVD in solid organ

274 pithelial cells require both the caspase and serine protease inhibitors to efficiently prevent apopto

275 We have characterized a Kazal family serine protease inhibitor, Toxoplasma gondii protease in

276 y the pan-caspase inhibitor zVAD-fmk and the serine protease inhibitor TPCK, but not the caspase-3 in

277 d the thermodynamics of binding of the Kazal serine protease inhibitor, turkey ovomucoid third domain

278 ied the functions of the Arabidopsis UNUSUAL SERINE PROTEASE INHIBITOR (UPI) gene, which encodes an 8

279 at alpha-1 antitrypsin (AAT; Prolastin-C), a serine protease inhibitor used for the treatment of AAT

280 otease TMPRSS2, but Zhou et al. found that a serine protease inhibitor was more protective than a cat

281 esign and synthesis of a novel iodine-labile serine protease inhibitor was realized by the use of an

282 SerpinA3N, a serine protease inhibitor, was upregulated in the dorsal

283 dentified from a diverse library of internal serine protease inhibitors, was originally designed as a

284 Finally, using selective serine protease inhibitors, we determined that PR3 activ

285 r efforts toward a second generation HCV NS3 serine protease inhibitor were directed at improving the

286 The serine protease inhibitors were able to block killing by

287 The resulting potent serine protease inhibitors were designed from lead molec

288 ked by metalloproteinase inhibitors, whereas serine protease inhibitors were ineffective.

289 The NS3/4A serine protease inhibitors were the first of these to be

290 Maspin is a tumor-suppressor serpin (serine protease inhibitor), which inhibits cell invasion

291 SLPI is a secreted serine protease inhibitor, which is overexpressed in a n

292 th inter-alpha-inhibitor (IalphaI), a potent serine protease inhibitor, which may be immobilized via

293 t this cascade is regulated by a serpin-type serine protease inhibitor, which plays an essential role

294 ay glands express Kunitz-type and non-Kunitz serine protease inhibitors, which might prevent proteoly

295 Cospin (PIC1) from Coprinopsis cinerea is a serine protease inhibitor with biochemical properties si

296 Maspin is a novel serine protease inhibitor with tumor suppressive activit

297 pentapeptide 2 are alpha-ketoamide-type HCV serine protease inhibitors with modest potency.

298 A combinatorial library of 400 serine protease inhibitors with the general structure Cb

299 Coapplication of serine protease inhibitors with the superbase normalized

300 odulating, and tissue-protective circulating serine-protease inhibitor, with levels that increase dur